Rocket Lab’s Rebound Accelerates as Analyst Upgrade and Index Inclusion Follow SpaceX-Driven Plunge

The space sector’s biggest stock story this month has been SpaceX’s record $75 billion initial public offering — but the fallout for Rocket Lab was swift and severe. On June 12, the smaller launch provider saw its shares tumble nearly 11% to €88.70 as institutional capital rotated en masse into the IPO. The selloff, however, proved short-lived. By the following Monday, Rocket Lab had recouped more than 6% of its losses, closing at €94.40 as a powerful double catalyst emerged: an analyst upgrade and an imminent promotion to the Nasdaq-100.

KeyBanc wasted no time responding to the rotation. Analyst Michael Leshock lifted his rating on Rocket Lab from “Sector Weight” to “Overweight” on June 15, slapping a $135 price target on the stock — roughly 40% above its then-trading level. He dismissed the previous Friday’s plunge as “misguided” and “unjustified,” arguing that the fundamental growth story remained untouched by the temporary capital shift. The market clearly agreed: the upgrade triggered an immediate relief rally, and the shares quickly climbed back above €94.

That fundamental story, as both KeyBanc and Stifel have pointed out, is underpinned by accelerating operational momentum. Rocket Lab’s first-quarter revenue hit $200.3 million, a 63% year-over-year surge that topped analyst expectations. The order backlog swelled to a record $2.2 billion, nearly doubling from the prior year, driven by increasing NASA activity, expanding defense budgets, and structural bottlenecks in global launch capacity. Stifel maintained its own $132 target, echoing the view that Rocket Lab is positioned to capture demand that competing providers struggle to fulfil.

Should investors sell immediately? Or is it worth buying Rocket Lab?

The real near-term trigger, however, is the company’s upcoming admission to the Nasdaq-100 on June 22. Passive index funds and exchange-traded products — including the $300 billion-plus Invesco QQQ trust — collectively oversee more than $800 billion in assets. Their mandatory buying of Rocket Lab shares will generate mechanical demand that analysts expect to provide a fresh tailwind. The timing coincides with an already busy launch schedule: Rocket Lab has more Electron rockets stacked in its New Zealand hangars than at any previous point in its history, and the first quarter alone brought five new contract wins.

Beyond the Electron workhorse, the Neutron programme remains the medium-term linchpin. The medium-lift vehicle, designed to challenge SpaceX’s dominance in heavier payload missions, is on track for a first flight later this year. A technical anomaly discovered during January testing has been fully resolved, according to KeyBanc, and the timeline remains intact. Success here would open a direct competitive front against SpaceX in the lucrative large-mission segment and could spark a re-rating of the entire company.

Technically, the stock has room to run. Despite a 45% year-to-date gain, Rocket Lab trades nearly 30% below its all-time high of €133.80 from May. Its relative strength index sits at 47 — squarely in neutral territory, suggesting the selloff erased any overbought conditions without triggering panic. The 200-day moving average of €63.28 lies far below the current price, confirming that the long-term uptrend remains intact.

With the Nasdaq switch next week and the Neutron first flight on the horizon, Rocket Lab enters the most intense phase of its corporate history. The near-term liquidity injection from index rebalancing is already priced in by some; the real test will be whether the company can deliver its first medium-lift launch within the year — and finally crack the monopoly that has defined the industry for a decade.

Ad

Rocket Lab Stock: New Analysis - 16 June

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

en | US7731211089 | ROCKET | boerse | 69549261 |